Advances in the diagnosis and treatment of nonalcoholic fatty liver disease-related liver fibrosis / 临床肝胆病杂志

ABSTRACT

Nonalcoholic fatty liver disease (NAFLD) is becoming the most common chronic liver disease in the world. From the perspective of its disease spectrum, nonalcoholic steatohepatitis (NASH) is a form of disease progression and can progress to liver fibrosis, leading to NAFLD-related liver cirrhosis and liver cancer. NASH-related liver fibrosis is closely associated with prognosis, and effective measures are urgently needed for the diagnosis and intervention of disease progression. This article summarizes the research advances in the diagnosis and treatment of NAFLD-related liver fibrosis.